The Relationships Between Personal Identity, Autobiographical Memory and Future Thinking in People With Multiple Sclerosis

Launched by CENTRE D'INVESTIGATION CLINIQUE ET TECHNOLOGIQUE 805 · Dec 5, 2022

Keywords

ClinConnect Summary

This clinical trial is studying how personal identity, memories of past experiences, and thoughts about the future are related for people with relapsing-remitting multiple sclerosis (MS). Researchers want to understand how living with MS affects a person's sense of self and how they view their future. They are particularly interested in whether having MS becomes a part of someone's identity and how this affects their emotional well-being and quality of life. The study aims to find new ways to support and care for individuals with MS by identifying helpful strategies based on these relationships.

To participate in the trial, individuals must be between 18 and 55 years old, be native French speakers, and have access to a computer or tablet with internet capabilities. For those with MS, they must have a confirmed diagnosis of relapsing-remitting MS and not have experienced a relapse or received certain treatments in the month before joining. Healthy individuals can also participate if they match the age, gender, and education level of the MS participants. Participants can expect to engage in activities that help researchers learn more about their experiences and feelings related to identity and memory in the context of MS.

Gender

ALL

Eligibility criteria

• For the clinical group:
• Inclusion Criteria:
• • Diagnosis of relapsing-remitting MS according to the McDonald's revised diagnostic criteria
• • People aged between 18 and 55
• • French native speaker
• • Access to a computer or tablet, equipped with internet access, a camera and a microphone
• Non-inclusion Criteria:
• • MS relapse in the month prior to the inclusion
• • Treatment with corticosteroids during the month preceding the inclusion
• • Form of MS other than the relapsing-remitting form
• • Neurological history (other than MS for patients), history or current presence of psychiatric disorders (e.g., depression, anxiety disorders, schizophrenia), substance abuse (e.g., alcohol, cannabis; past or present)
• • Other diagnosed chronic pathology(ies) (other than MS for patients)
• • Severe cognitive impairment
• • Persons mentioned in Articles L1121-6 to L1121-8 in the French law (minors, persons deprived of liberty, adults subject to protective measures)
• For the control group:
• Inclusion Criteria:
• • People aged between 18 and 55
• • Matched in age, gender and level in education
• • French native speaker
• • Access to a computer or tablet, equipped with internet access, a camera and a microphone
• Non-inclusion Criteria:
• • Neurological history (other than MS for patients), history or current presence of psychiatric disorders (e.g., depression, anxiety disorders, schizophrenia), substance abuse (e.g., alcohol, cannabis; past or present)
• • Other diagnosed chronic pathology(ies) (other than MS for patients)
• • Severe cognitive impairment
• • Persons mentioned in Articles L1121-6 to L1121-8 in the French law (minors, persons deprived of liberty, adults subject to protective measures)